Prominent cardiologist Dr. Peter McCullough on Thursday called on president-elect Donald Trump to pull the COVID-19 vaccine ...

They found that mRNA vaccines that target C. diff cells and the toxins they produce generated a lasting immune response in ...

Dr. Emmanuel Walter, chief medical office of the Duke Human Vaccine Institute and professor of pediatrics at Duke University ...

Health officials say it's important to get flu and COVID-19 vaccines ahead of the holidays when respiratory bugs tend to ...

The top-line beat was led by its higher than anticipated sales of Covid-19 vaccine, while its recently approved respiratory syncytial virus vaccine raked in just $10 ...

With the possibility of Robert F. Kennedy, Jr. being involved in health policy in the next administration, vaccination – ...

For effective prevention, vaccines must stimulate mucosal immunity – an immune response in the respiratory tract where ...

The optimal time to get your seasonal flu shot, according to the Food and Drug Administration (FDA), is right now: flu ...

Moderna stock rises as Q3 revenue beats estimates at $1.83 billion, driven by strong U.S. COVID-19 vaccine sales. EPS of $0.03 exceeds expectations.

Recent research suggests that protective antibodies from Covid-19 vaccines, specifically the mRNA type, tend to decline ...

PHILADELPHIA — The same technology that saved millions of lives during the COVID-19 pandemic appears to hold promise against another scourge of infectious disease, according to new research from the ...

Issuer: CureVac / Key word (s): Conference CureVac to Present at the 12th International mRNA Health Conference 04.11.2024 / 13:00 CET/CEST The issuer is solely responsible for the content of this ...